Rheumatoid Arthritis
Rheumatoid Arthritis
Advertisement
Rebecca AraujoRheumatoid Arthritis | November 27, 2023
Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure.
Read More
Rebecca AraujoRheumatoid Arthritis | November 9, 2023
Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans.
Mithu Maheswaranathan, MDRheumatoid Arthritis | October 11, 2023
A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort.
Patrick DalyRheumatoid Arthritis | July 26, 2023
Abatacept improved outcomes for rheumatoid arthritis refractory to methotrexate or TNFi versus rituximab or tocilizumab.
Mithu Maheswaranathan, MDRheumatoid Arthritis | October 11, 2023
Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis.
Rebecca AraujoRheumatoid Arthritis | June 5, 2023
The American College of Rheumatology has released new recommendations for the management of rheumatoid arthritis.
Patrick DalyRheumatoid Arthritis | May 30, 2023
Patients with rheumatoid arthritis with lower hemoglobin levels may be more likely to have increased progression over time.
Patrick DalyRheumatoid Arthritis | May 16, 2023
Researchers established tranexamic acid was safe and effective in patients with rheumatoid arthritis following TKA.
Patrick DalyRheumatoid Arthritis | October 16, 2023
In a recent study, published in Rheumatology International, researchers sought to determine predictive variables for ...
Patrick DalyRheumatoid Arthritis | October 16, 2023
Telomere length shortening plays a role in the deterioration and death of various immune cells, leading to immune ...
Patrick DalyRheumatoid Arthritis | October 16, 2023
In the phase 4 AWARE study, researchers compared golimumab and infliximab in patients with rheumatoid arthritis. After ...
Patrick DalyPsoriatic Arthritis | April 10, 2023
Researchers, led by Gerd R Burmester, conducted a clinical trial to evaluate the long-term safety outcomes of ...
Patrick DalyRheumatoid Arthritis | April 7, 2023
Researchers sought to determine if immunomodulators and related combination therapy strategies reduced cardiovascular ...
Rebecca AraujoRheumatoid Arthritis | April 7, 2023
ABBV-3373, a novel antibody drug conjugate (ADC) for the treatment of rheumatoid arthritis, demonstrated similar ...
Patrick DalyVTE | August 29, 2023
In the ORAL Surveillance study, researchers found tofacitinib showed a higher incidence of pulmonary embolism compared ...
Patrick DalyRheumatoid Arthritis | April 7, 2023
In a recent meta-analysis, published in RMD Open, researchers sought to identify laboratory biomarkers that predicted ...
Patrick DalyRheumatoid Arthritis | April 7, 2023
Using data from the SEAM-RA (Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With ...
Patrick DalyRheumatoid Arthritis | April 13, 2023
In a recent meta-analysis, researchers found that patients with rheumatoid arthritis have an increased risk of ...
Patrick DalyRheumatoid Arthritis | April 7, 2023
In a meta-analysis published in Frontiers in Immunology, researchers evaluated the safety and efficacy of Janus kinase ...
Patrick DalyRheumatoid Arthritis | April 7, 2023
Researches, led by Giuseppe Germanò, proposed that ultrasound assessment may improve the evaluation of disease activity ...
Advertisement
Advertisement
Advertisement
Latest News

February 22, 2024